Research Article

Use of FreeStyle Libre Flash Monitor Register in the Netherlands (FLARE-NL1): Patient Experiences, Satisfaction, and Cost Analysis

Table 1

Inclusion criteria for target groups.

(1) Patients with “hypoglycemia unawareness” and moderate to severe hypoglycemic episodes after an average of six or more measurements per day over the past year and despite intensive support from a diabetes team
(2) Patients with unexpected hypoglycemia after obtaining an average of six or more measurements per day over the past year and despite intensive support from a diabetes team
(3) Patients treated with insulin who, despite maximal efforts (frequent blood monitoring and proper lifestyle management) and intensive support from the diabetes team, do not reach acceptable glycemic control, as evidenced by a mean HbA1c >64 mmol/mol (8.0%) over the year preceding the inclusion
(4) Patients who have an occupation whereby loss of sensation in the fingers by frequent use of BGMs may lead to disability (e.g., musicians) and who are under other circumstances would be advised by the healthcare team to perform frequent blood glucose measurements to better control their diabetes
(5) Patients who have an occupation whereby even rarely occurring hypoglycemic episodes would lead to a situation endangering themselves and/or others (e.g., bus and lorry drivers, school teachers, and sports trainers).
(6) Patients who are already eligible for CGM according to Dutch regulations;
children with type 1 diabetes (up to 18 years);
pregnancy wish and pregnancy in diabetic individuals (type 1 and type 2);
adults with type 1 diabetes with poor metabolic control (HbA1c >64 mmol/mol) for a longer period.
(7) Patients already using the FSL-FM at their own expense but fall into one of the categories described above